Novel Findings in Drug-Induced Dendritic Cell Tolerogenicity

Dendritic cells (DCs) constitute a unique set of antigen-presenting cells (APCs), equipped with the potential to initiate strong immune responses as well as to critically regulate immunity. Tolerogenic or “alternatively activated” DCs show remarkable properties in regulating immune responses both in vitro and in vivo. Furthermore, tolerogenic DCs are now beginning to be tested in clinical studies. Use of pharmacological agents to induce maturation-resistant tolerogenic DCs is a popular approach. In this review, we will discuss already recognized, as well as recently discovered, potential pharmacological agents, their mechanism of action, and the way in which they induce tolerance in DCs.

[1]  L. Yu,et al.  Antigen‐dependent immunotherapy of non‐obese diabetic mice with immature dendritic cells , 2010, Clinical and experimental immunology.

[2]  U. Švajger,et al.  Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation , 2010, Immunology.

[3]  J. Ríos.  Effects of triterpenes on the immune system. , 2010, Journal of ethnopharmacology.

[4]  J. Isaacs,et al.  Development of Dendritic Cell-Based Immunotherapy for Autoimmunity , 2010, International reviews of immunology.

[5]  Zhu Wei-guo,et al.  PPAR‐γ agonist inhibits Ang II‐induced activation of dendritic cells via the MAPK and NF‐κB pathways , 2010, Immunology and cell biology.

[6]  Matthew J. Jenny,et al.  The tryptophan photoproduct 6-formylindolo[3,2-b]carbazole (FICZ) binds multiple AHRs and induces multiple CYP1 genes via AHR2 in zebrafish. , 2009, Chemico-biological interactions.

[7]  S. Pervaiz,et al.  Resveratrol: its biologic targets and functional activity. , 2009, Antioxidants & redox signaling.

[8]  A. Eljaafari,et al.  IFN-γ, as Secreted during an Alloresponse, Induces Differentiation of Monocytes into Tolerogenic Dendritic Cells, Resulting in FoxP3+ Regulatory T Cell Promotion1 , 2009, The Journal of Immunology.

[9]  D. von Bubnoff,et al.  Tryptophan Deprivation Induces Inhibitory Receptors ILT3 and ILT4 on Dendritic Cells Favoring the Induction of Human CD4+CD25+ Foxp3+ T Regulatory Cells1 , 2009, The Journal of Immunology.

[10]  David R Bickers,et al.  Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. , 2009, Archives of biochemistry and biophysics.

[11]  A. Bode,et al.  Epigallocatechin 3-Gallate and Green Tea Catechins: United They Work, Divided They Fail , 2009, Cancer Prevention Research.

[12]  E. Rajnavölgyi,et al.  Transient receptor potential vanilloid‐1 signaling inhibits differentiation and activation of human dendritic cells , 2009, FEBS letters.

[13]  M. Trucco,et al.  Dendritic cell-based therapy in Type 1 diabetes mellitus , 2009, Expert review of clinical immunology.

[14]  H. Tachibana.  Molecular basis for cancer chemoprevention by green tea polyphenol EGCG. , 2009, Forum of nutrition.

[15]  A. Rudensky,et al.  In Vivo Analysis of Dendritic Cell Development and Homeostasis , 2009, Science.

[16]  Jeffrey M. Wilson,et al.  The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells 1 , 2009, The Journal of Immunology.

[17]  K. Zhu,et al.  Imiquimod inhibits the differentiation but enhances the maturation of human monocyte-derived dendritic cells. , 2009, International immunopharmacology.

[18]  S. Abdel-Malek,et al.  Epicatechin suppresses IL-6, IL-8 and enhances IL-10 production with NF-kappaB nuclear translocation in whole blood stimulated system. , 2009, Neuro endocrinology letters.

[19]  K. Elkon,et al.  Ly6Clow Monocytes Differentiate into Dendritic Cells and Cross-Tolerize T Cells through PDL-11 , 2009, The Journal of Immunology.

[20]  Hyung Keun Kim,et al.  Rosmarinic acid down-regulates the LPS-induced production of monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) via the MAPK pathway in bone-marrow derived dendritic cells. , 2008, Molecules and cells.

[21]  M. Merad,et al.  Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes , 2008, The Journal of experimental medicine.

[22]  J. Isaacs,et al.  LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells , 2008, Journal of leukocyte biology.

[23]  F. Matsumura,et al.  Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. , 2008, Biochemical and biophysical research communications.

[24]  A. Kelly,et al.  Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. , 2008, Blood.

[25]  B. Fedoric,et al.  Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction. , 2008, Immunology letters.

[26]  N. Prasadarao,et al.  Outer Membrane Protein A Expression in Escherichia coli K1 Is Required to Prevent the Maturation of Myeloid Dendritic Cells and the Induction of IL-10 and TGF-β1 , 2008, The Journal of Immunology.

[27]  K. Mills,et al.  Adenylate cycalse toxin of Bordetella pertussis inhibits TLR‐induced IRF‐1 and IRF‐8 activation and IL‐12 production and enhances IL‐10 through MAPK activation in dendritic cells , 2008, Journal of leukocyte biology.

[28]  C. Dinarello,et al.  Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. , 2008, The Journal of clinical investigation.

[29]  A. J. Valente,et al.  Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. , 2008, American journal of physiology. Heart and circulatory physiology.

[30]  Melanie Bahlo,et al.  Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo , 2007, Nature Immunology.

[31]  D. Jarrossay,et al.  Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow , 2007, Nature Immunology.

[32]  L. Kiessling,et al.  Non-carbohydrate inhibitors of the lectin DC-SIGN. , 2007, Journal of the American Chemical Society.

[33]  L. Pirola,et al.  Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. , 2007, The Biochemical journal.

[34]  Yuzhang Wu,et al.  Sinomenine promotes differentiation but impedes maturation and co-stimulatory molecule expression of human monocyte-derived dendritic cells. , 2007, International immunopharmacology.

[35]  Min Goo Lee,et al.  Sphingosine kinase inhibitor suppresses dendritic cell migration by regulating chemokine receptor expression and impairing p38 mitogen‐activated protein kinase , 2007, Immunology.

[36]  Ranjeny Thomas,et al.  Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB. , 2007, Arthritis and rheumatism.

[37]  L. Jermiin,et al.  Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. , 2007, Gene.

[38]  Jun Sun,et al.  Involvement of the vitamin D receptor in the regulation of NF-κB activity in fibroblasts , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[39]  G. Ji,et al.  [The effects of sinomenine on the expresssion of ICAM-1 and IL-2 during the rejection of rat cardiac allograft]. , 2007, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[40]  R. Steinman,et al.  Dendritic cells with TGF-β1 differentiate naïve CD4+CD25− T cells into islet-protective Foxp3+ regulatory T cells , 2007, Proceedings of the National Academy of Sciences.

[41]  T. Klockgether,et al.  Peroxisome Proliferator-Activated Receptor γ Control of Dendritic Cell Function Contributes to Development of CD4+ T Cell Anergy , 2007, The Journal of Immunology.

[42]  Steffen Jung,et al.  Monocytes give rise to mucosal, but not splenic, conventional dendritic cells , 2007, The Journal of experimental medicine.

[43]  B. Spiegelman,et al.  International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors , 2006, Pharmacological Reviews.

[44]  So Ri Kim,et al.  Modulation of Airway Remodeling and Airway Inflammation by Peroxisome Proliferator-Activated Receptor γ in a Murine Model of Toluene Diisocyanate-Induced Asthma1 , 2006, The Journal of Immunology.

[45]  Giuseppe Leone,et al.  Tolerogenic dendritic cells: cytokine modulation comes of age. , 2006, Blood.

[46]  R. Lechler,et al.  Aspirin‐Treated Human DCs Up‐Regulate ILT‐3 and Induce Hyporesponsiveness and Regulatory Activity in Responder T Cells , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[47]  Motohiko Suzuki,et al.  Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine , 2006, Arthritis research & therapy.

[48]  Katharina Fleischhauer,et al.  Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.

[49]  Nan Li,et al.  Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation. , 2006, Biochemical and biophysical research communications.

[50]  M. Koupenova,et al.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. , 2006, The Journal of clinical investigation.

[51]  R. Schwarcz,et al.  Kynurenine Pathway Enzymes in Dendritic Cells Initiate Tolerogenesis in the Absence of Functional IDO1 , 2006, The Journal of Immunology.

[52]  S. Ferrari,et al.  Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. , 2006, Blood.

[53]  M. Belvisi,et al.  Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. , 2006, European journal of pharmacology.

[54]  M. Pallardy,et al.  GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. , 2006, Blood.

[55]  D. Giordano,et al.  Nitric oxide and cGMP protein kinase (cGK) regulate dendritic-cell migration toward the lymph-node-directing chemokine CCL19. , 2006, Blood.

[56]  Ana Cumano,et al.  A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells , 2006, Science.

[57]  L. Liau,et al.  The TLR-7 Agonist, Imiquimod, Enhances Dendritic Cell Survival and Promotes Tumor Antigen-Specific T Cell Priming: Relation to Central Nervous System Antitumor Immunity1 , 2006, The Journal of Immunology.

[58]  Giuseppe Penna,et al.  Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. , 2005, Blood.

[59]  R. Kumar,et al.  Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Xin Chen,et al.  Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. , 2005, Blood.

[61]  David Pozo,et al.  Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[62]  S. Akira,et al.  Specific Inhibition of MyD88-Independent Signaling Pathways of TLR3 and TLR4 by Resveratrol: Molecular Targets Are TBK1 and RIP1 in TRIF Complex1 , 2005, The Journal of Immunology.

[63]  X. Mao,et al.  Triptolide affects the differentiation, maturation and function of human dendritic cells. , 2005, International immunopharmacology.

[64]  D. Philpott,et al.  Synergistic stimulation of human monocytes and dendritic cells by Toll‐like receptor 4 and NOD1‐ and NOD2‐activating agonists , 2005, European journal of immunology.

[65]  M. Clare-Salzler,et al.  Dexamethasone Induces IL‐10‐Producing Monocyte‐Derived Dendritic Cells with Durable Immaturity , 2005, Scandinavian journal of immunology.

[66]  Soon-Cheol Ahn,et al.  Curcumin Inhibits Immunostimulatory Function of Dendritic Cells: MAPKs and Translocation of NF-κB as Potential Targets1 , 2005, The Journal of Immunology.

[67]  P. Verginis,et al.  Tolerogenic Semimature Dendritic Cells Suppress Experimental Autoimmune Thyroiditis by Activation of Thyroglobulin-Specific CD4+CD25+ T Cells1 , 2005, The Journal of Immunology.

[68]  Jin Xie,et al.  Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells. , 2005, Experimental hematology.

[69]  M. Mock,et al.  Anthrax Edema Toxin Cooperates with Lethal Toxin to Impair Cytokine Secretion during Infection of Dendritic Cells1 , 2005, The Journal of Immunology.

[70]  K. Stuhlmeier,et al.  The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function , 2005, Arthritis research & therapy.

[71]  B. P. Kota,et al.  An overview on biological mechanisms of PPARs. , 2005, Pharmacological research.

[72]  A. Santoro,et al.  Are interleukin-16 and thrombopoietin new tools for the in vitro generation of dendritic cells? , 2004, Blood.

[73]  A. Bringmann,et al.  PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. , 2004, Blood.

[74]  T. Huizinga,et al.  Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells. , 2004, Arthritis and rheumatism.

[75]  C. Kunsch,et al.  Sphingosine kinase-1 mediates TNF-alpha-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow. , 2004, American journal of physiology. Heart and circulatory physiology.

[76]  A. Styche,et al.  Antisense Oligonucleotides Down-Regulating Costimulation Confer Diabetes-Preventive Properties to Nonobese Diabetic Mouse Dendritic Cells1 , 2004, The Journal of Immunology.

[77]  K. Migita,et al.  Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL‐1β stimulated rheumatoid synovial fibroblasts , 2004, Clinical and experimental immunology.

[78]  Weicheng Wu,et al.  Sphingosine Kinase Protects Lipopolysaccharide-Activated Macrophages from Apoptosis , 2004, Molecular and Cellular Biology.

[79]  Nan Li,et al.  Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation. , 2004, Biochemical and biophysical research communications.

[80]  L. Weiss,et al.  Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells. , 2004, International immunology.

[81]  S. Goto,et al.  Platelets, after Exposure to a High Shear Stress, Induce IL-10-Producing, Mature Dendritic Cells In Vitro1 , 2004, The Journal of Immunology.

[82]  A. Lovett-racke,et al.  Peroxisome Proliferator-Activated Receptor α Agonists as Therapy for Autoimmune Disease1 , 2004, The Journal of Immunology.

[83]  L. Adorini,et al.  Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. , 2004, Seminars in immunology.

[84]  D. Munn,et al.  Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells1 , 2004, The Journal of Immunology.

[85]  T. Geijtenbeek,et al.  Self- and nonself-recognition by C-type lectins on dendritic cells. , 2004, Annual review of immunology.

[86]  D. Foster,et al.  Interleukin-21 inhibits dendritic cell activation and maturation. , 2003, Blood.

[87]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[88]  Yadi Wu,et al.  The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response. , 2003, International immunopharmacology.

[89]  Antonio Lanzavecchia,et al.  Activation of src‐family tyrosine kinases by LPS regulates cytokine production in dendritic cells by controlling AP‐1 formation , 2003, European journal of immunology.

[90]  Brian D. Lee,et al.  Discovery and evaluation of inhibitors of human sphingosine kinase. , 2003, Cancer research.

[91]  T. Ichim,et al.  LF15‐0195 generates tolerogenic dendritic cells by suppression of NF‐κB signaling through inhibition of IKK activity , 2003, Journal of leukocyte biology.

[92]  O. Leavy,et al.  Cholera Toxin Promotes the Induction of Regulatory T Cells Specific for Bystander Antigens by Modulating Dendritic Cell Activation 1 , 2003, The Journal of Immunology.

[93]  P. Robbins,et al.  Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. , 2003, Diabetes.

[94]  P. Soulard,et al.  Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity. , 2003, International immunology.

[95]  D. Mancini,et al.  High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. , 2003, Transplant immunology.

[96]  A. Maghazachi,et al.  Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation. , 2003, Blood.

[97]  A. Thomson,et al.  Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. , 2003, Blood.

[98]  H. Harizi,et al.  Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes , 2003, Journal of leukocyte biology.

[99]  M. Sitkovsky,et al.  The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. , 2003, Microbes and infection.

[100]  Tomoki Ito,et al.  Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets , 2003, Immunology.

[101]  K. Skak,et al.  Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression. , 2003, Blood.

[102]  R. Offringa,et al.  Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression. , 2003, Blood.

[103]  T. Kielian,et al.  Effects of peroxisome proliferator‐activated receptor‐γ agonists on central nervous system inflammation , 2003, Journal of neuroscience research.

[104]  P. Allavena,et al.  Rapamycin impairs antigen uptake of human dendritic cells1 , 2003, Transplantation.

[105]  T. Nohara,et al.  Evaluation of the Anti-oxidative Effect (in vitro) of Tea Polyphenols , 2003, Bioscience, biotechnology, and biochemistry.

[106]  A. Thompson,et al.  Induction of immune tolerance by dendritic cells: Implications for preventative and therapeutic immunotherapy of autoimmune disease , 2002, Immunology and cell biology.

[107]  R. Tuskan,et al.  Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte‐derived dendritic cells and dominantly inhibit cytokine production through a cAMP‐dependent pathway , 2002, Journal of leukocyte biology.

[108]  H. Uchi,et al.  The sesquiterpene lactone parthenolide inhibits LPS- but not TNF-alpha-induced maturation of human monocyte-derived dendritic cells by inhibition of the p38 mitogen-activated protein kinase pathway. , 2002, The Journal of allergy and clinical immunology.

[109]  J. Ward,et al.  Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis , 2002, Journal of Neuroimmunology.

[110]  W. Brugger,et al.  Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor γ1 , 2002, The Journal of Immunology.

[111]  A. Thomson,et al.  Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells. , 2002, Blood.

[112]  T. Mayumi,et al.  PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice. , 2002, European journal of pharmacology.

[113]  R. Noelle,et al.  Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. , 2002, Cellular immunology.

[114]  P. Libby,et al.  PPAR Activators as Antiinflammatory Mediators in Human T Lymphocytes: Implications for Atherosclerosis and Transplantation-Associated Arteriosclerosis , 2002, Circulation research.

[115]  A. Enk,et al.  CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. , 2002, Blood.

[116]  M. Colonna,et al.  Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4 , 2002, Nature Immunology.

[117]  J. Cambier,et al.  Introduction: multifaceted roles of lipids and their catabolites in immune cell signaling. , 2002, Seminars in immunology.

[118]  R. Fauchet,et al.  Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. , 2002, Human immunology.

[119]  Philippe Gosset,et al.  Peroxisome proliferator‐activated receptor γ  activators affect the maturation of human monocyte‐derived dendritic cells , 2001 .

[120]  Michel C. Nussenzweig,et al.  Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.

[121]  J. Buchner,et al.  Coordinated ATP Hydrolysis by the Hsp90 Dimer* , 2001, The Journal of Biological Chemistry.

[122]  P. Mandrekar,et al.  Tacrolimus and Cyclosporine A Inhibit Allostimulatory Capacity and Cytokine Production of Human Myeloid Dendritic Cells , 2001, Journal of Investigative Medicine.

[123]  Fajun Yang,et al.  The Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate Blocks Nuclear Factor-κB Activation by Inhibiting IκB Kinase Activity in the Intestinal Epithelial Cell Line IEC-6 , 2001 .

[124]  R. Wood,et al.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line , 2001, BMC Physiology.

[125]  J. Falck,et al.  Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. , 2001, Molecular pharmacology.

[126]  C. Uyttenhove,et al.  IL-6 Inhibits the Tolerogenic Function of CD8α+ Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase1 , 2001, The Journal of Immunology.

[127]  S. Chung,et al.  Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by parthenolide, a predominant sesquiterpene lactone in Tanacetum parthenium: involvement of nuclear factor-kappaB. , 2001, Immunology letters.

[128]  J. D. de Fijter,et al.  Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. , 2001, Blood.

[129]  Simon C Watkins,et al.  Aspirin Inhibits In Vitro Maturation and In Vivo Immunostimulatory Function of Murine Myeloid Dendritic Cells1 , 2001, The Journal of Immunology.

[130]  Fajun Yang,et al.  The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. , 2001, Molecular pharmacology.

[131]  V. Kindler,et al.  A Critical Role for p38 Mitogen-Activated Protein Kinase in the Maturation of Human Blood-Derived Dendritic Cells Induced by Lipopolysaccharide, TNF-α, and Contact Sensitizers , 2001, The Journal of Immunology.

[132]  P. Yaqoob,et al.  The effects of phenolic components of tea on the production of pro- and anti-inflammatory cytokines by human leukocytes in vitro. , 2001, Cytokine.

[133]  F. Di Virgilio,et al.  Extracellular ATP Induces a Distorted Maturation of Dendritic Cells and Inhibits Their Capacity to Initiate Th1 Responses1 , 2001, The Journal of Immunology.

[134]  Nina Bhardwaj,et al.  Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[135]  U. Grohmann,et al.  CD40 Ligation Ablates the Tolerogenic Potential of Lymphoid Dendritic Cells1 , 2001, The Journal of Immunology.

[136]  K. Kawa,et al.  Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promote the development of dendritic cells that drive CD4+ T cells toward Th2 responses , 2000, Journal of leukocyte biology.

[137]  Dayer Jm,et al.  Leflunomide: mode of action in the treatment of rheumatoid arthritis , 2000, Annals of the rheumatic diseases.

[138]  F. Breedveld,et al.  Leflunomide: mode of action in the treatment of rheumatoid arthritis , 2000, Annals of the rheumatic diseases.

[139]  T. Luger,et al.  Mycophenolate Mofetil Impairs the Maturation and Function of Murine Dendritic Cells1 , 2000, The Journal of Immunology.

[140]  Asim Khwaja,et al.  The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte–derived dendritic cells , 2000 .

[141]  D. Sauder,et al.  Immunomodulatory and pharmacologic properties of imiquimod. , 2000, Journal of the American Academy of Dermatology.

[142]  P. Allavena,et al.  Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells1 , 2000, The Journal of Immunology.

[143]  O. Majdic,et al.  1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. , 2000, Experimental hematology.

[144]  W. V. Berghe,et al.  Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[145]  Milton W. Taylor,et al.  Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell Proliferation , 2000, The Journal of Immunology.

[146]  K. Irie,et al.  TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. , 2000, Molecular cell.

[147]  J. D. de Fijter,et al.  The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. , 2000, European journal of immunology.

[148]  L. Adorini,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.

[149]  T. Hofmann,et al.  The Antiinflammatory Sesquiterpene Lactone Parthenolide Inhibits NF-κB by Targeting the IκB Kinase Complex , 1999, The Journal of Immunology.

[150]  C. Ioannides,et al.  Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism. , 1999, Biochemistry.

[151]  C. Janeway,et al.  ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. , 1999, Genes & development.

[152]  P. Allavena,et al.  Glucocorticoids affect human dendritic cell differentiation and maturation. , 1999, Journal of immunology.

[153]  D. Munn,et al.  Inhibition of  T Cell Proliferation by Macrophage Tryptophan Catabolism , 1999, The Journal of experimental medicine.

[154]  J. Ninomiya-Tsuji,et al.  The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.

[155]  S. Spiegel.  Sphingosine 1‐phosphate: a prototype of a new class of second messengers , 1999, Journal of leukocyte biology.

[156]  Hanno Langen,et al.  Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA , 1999, The Journal of experimental medicine.

[157]  M. Lotze,et al.  Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. , 1998, Transplantation.

[158]  R. Steinman,et al.  Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. , 1998, Science.

[159]  W. Gu,et al.  Inhibition of type II collagen-induced arthritis in rats by triptolide. , 1998, International journal of immunopharmacology.

[160]  K. Miyazono,et al.  ASK1 is essential for JNK/SAPK activation by TRAF2. , 1998, Molecular cell.

[161]  D. Munn,et al.  Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.

[162]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[163]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[164]  N. Mackman,et al.  Lipopolysaccharide Induction of the Tumor Necrosis Factor-α Promoter in Human Monocytic Cells , 1997, The Journal of Biological Chemistry.

[165]  T. Greten,et al.  Endogenous Adenosine Curtails Lipopolysaccharide‐Stimulated Tumour Necrosis Factor Synthesis , 1997, Scandinavian journal of immunology.

[166]  Minoru Takagi,et al.  Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.

[167]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[168]  A. Baldwin,et al.  Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.

[169]  Joseph A. DiDonato,et al.  Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.

[170]  T. Testerman,et al.  Cytokine induction by the immunomodulators imiquimod and S‐27609 , 1995, Journal of leukocyte biology.

[171]  J. Cidlowski,et al.  Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors , 1995, Molecular and cellular biology.

[172]  J. Blay,et al.  Adenosine as a possible inhibitor of killer T‐cell activation in the microenvironment of solid tumours , 1994, International journal of cancer.

[173]  Milton W. Taylor,et al.  Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[174]  R. Li,et al.  [Comparative clinical study of rheumatoid arthritis treated by triptolide and an ethyl acetate extract of Tripterygium wilfordii]. , 1990, Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine.

[175]  X. Tao,et al.  A prospective, controlled, double-blind, cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis. , 1989, Chinese medical journal.

[176]  H. van Belle,et al.  Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. , 1987, The American journal of physiology.

[177]  S. Wasserman,et al.  Adenosine release from stimulated mast cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[178]  K. Han,et al.  Clinical observations on Tripterygium wilfordii in treatment of 26 cases of discoid lupus erythematosus. , 1983, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[179]  R Rubio,et al.  Brain adenosine concentration during hypoxia in rats. , 1981, The American journal of physiology.

[180]  Y. T. Li,et al.  Hydroxypiperaquine phosphate in treating chloroquine resistant falciparum malaria. , 1981, Chinese medical journal.

[181]  C. Gilmore,et al.  Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. , 1972, Journal of the American Chemical Society.

[182]  H. Nagawa,et al.  Epigallocatechin gallate affects human dendritic cell differentiation and maturation. , 2008, The Journal of allergy and clinical immunology.

[183]  N. Prasadarao,et al.  Outer membrane protein A expression in Escherichia coli K1 is required to prevent the maturation of myeloid dendritic cells and the induction of IL-10 and TGF-beta. , 2008, Journal of immunology.

[184]  F. Mennechet,et al.  Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. , 2006, Blood.

[185]  Marietta F. Wright,et al.  Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells. , 2006, Diabetes.

[186]  A. Thomson,et al.  Dendritic cells: emerging pharmacological targets of immunosuppressive drugs , 2004, Nature Reviews Immunology.

[187]  A. Lovett-racke,et al.  Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. , 2004, Journal of immunology.

[188]  Michael Karin,et al.  The IKK NF-kappa B system: a treasure trove for drug development. , 2004, Nature reviews. Drug discovery.

[189]  V. Adhami,et al.  Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. , 2003, Neoplasia.

[190]  D. Keskin,et al.  Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. , 2002, International immunology.

[191]  D. Keskin,et al.  Functional expression of indoleamine 2,3-dioxygenase by murine CD8α+ dendritic cells , 2002 .

[192]  D. Munn,et al.  Prevention of T cell–driven complement activation and inflammation by tryptophan catabolism during pregnancy , 2001, Nature Immunology.

[193]  P. Tak,et al.  NF-kappaB: a key role in inflammatory diseases. , 2001, The Journal of clinical investigation.

[194]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[195]  B Staels,et al.  Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. , 2001, European journal of immunology.

[196]  P. Tak,et al.  NF-κB: a key role in inflammatory diseases , 2001 .

[197]  K M Ardeshna,et al.  The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. , 2000, Blood.

[198]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[199]  L. Adorini,et al.  1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. , 2000, Journal of immunology.

[200]  T. Hofmann,et al.  The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. , 1999, Journal of immunology.

[201]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[202]  K. Schulze-Osthoff,et al.  Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. , 1998, The Journal of biological chemistry.

[203]  N. Mackman,et al.  Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. , 1997, The Journal of biological chemistry.

[204]  M. Sitkovsky,et al.  Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. , 1997, Blood.

[205]  M. Karin,et al.  Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. , 1995, Science.

[206]  A. Baldwin,et al.  Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. , 1995, Science.

[207]  R. Agarwal,et al.  Green tea and skin--anticarcinogenic effects. , 1994, The Journal of investigative dermatology.

[208]  B. Cronstein.  Adenosine, an endogenous anti-inflammatory agent. , 1994, Journal of applied physiology.

[209]  W. Bors,et al.  Radical scavenging by flavonoid antioxidants. , 1987, Free radical research communications.